|
||
PEOPLE & IDEAS |
Working at the interface between pathogen and host, Andrea Cooper investigates how the immune system responds to invasion by disease-causing organisms.
–producing T cells are lured into the lung tissue where they do direct battle with the invaders.
|
in the control of M. tuberculosis (1–4). And now at the Trudeau Institute, on the shores of Saranac Lake in upstate New York, Cooper, along with her husband John Pearl and the rest of her laboratory, is parsing out how cytokines secreted by DCs and T cells help orchestrate host immune responses against pathogens (5).
THE PATH TO PATHOGENS
Why did you want to become a biologist?
Do you know David Attenborough, the British broadcaster and naturalist? Well, he was kind of an inspiration for me. In fact, I wanted to go and count rock hyraxes in the savannah.
How did you make the jump to Leishmania parasites? That's a far cry from counting small, furry mammals.
My undergraduate project was on neuronal development in chicks, and while I was working on that I got really excited about cell biology and also the intricate interactions between hosts and pathogens. While I was finishing my undergraduate degree and preparing for final exams, I told my tutor that I was going to do a technical course and he said, "Oh, don't be silly, Andrea. You need to do your PhD!"
I got really excited as a scientist during graduate school at the London School of Hygiene & Tropical Medicine. My laboratory was working on mice, there were people doing human work, and there were also sand fly people—sand flies are the vectors of Leishmania. So although I wasn't really supposed to be working on sand flies, I got friendly with a guy who was doing sand fly stuff and we did some experiments together. And that was one of the papers for my thesis.
After graduate school, you were a postdoc at the NIH in Maryland. Interesting that once you moved to the US you never went back to work in the UK.
That's what my parents said too. I promised them I was only leaving [England] for two years, but I was drawn into the terrific resources that are available here. In Europe and the UK, scientists are a bit more constrained by funding so they're always very careful, whereas in the US we have a lot more resources.
Your next stop was Colorado State, and I see that you switched pathogens there.
Shall I tell you the real story about that?
Sure!
I had some hunting friends, and we went out West to do falconry in Wyoming. I really enjoyed the whole western experience and thought maybe we'd like to move out there to see what it's like. David Russell [now at Cornell University College of Veterinary Medicine] was a good friend of David Sacks, and I also knew him because he was a postdoc studying Leishmania when I was a graduate student in the UK. David Russell said he knew some people in Colorado who had a program in Mycobacterium tuberculosis, which would be a good model for me to know. And so he introduced me to Ian Orme at Colorado State. And when Ian and I met up, we decided it would be a great match. It was very fortuitous. Ian energized me to a great degree, not only about the science, but also about my career.
Do you still go hunting with falcons?
I still like to watch the birds, but it's not something that one can do as a hobby. The people who do falconry do it full-time. But I've stood next to golden eagles; I've stood next to gyrfalcons and all sorts of beautiful birds. You take them out hunting and it's a combination of bird, dog, and human. There's nothing artificial involved, no guns or anything. You simply go out and if you're lucky, you might get a sage grouse for dinner at the end of it.
|
response. In the absence of IL-12p70, although we get initial control of bacterial growth, it's not very long-lived. So IL-12p70 seems to be required to maintain long-lived, maximal IFN-
responses within the tissue. In the absence of IL-23, which drives the expansion of IL-17-producing T cells, we don't see a clear impact on infection for the first 100 days, but it seems that there may be an impact later, and we're working on that right now. We do know that in the absence of IL-23, you lose a substantial portion of the IL-17 response to M. tuberculosis.
What has your laboratory learned about the immune response induced by tuberculosis vaccines?
Vaccine-induced memory is slow to respond to aerosol delivery of M. tuberculosis. We think this is why vaccination works well to limit disseminated disease, but is less effective against pulmonary disease. We examined the early cellular response to aerosol infection of vaccinated mice and found that an early vaccine-dependent IL-17 response occurs in the lung, and this coincides with an accelerated local chemokine response. If this early IL-17 response is missing, then vaccine-induced memory in the form of an accelerated IFN-
response doesn't occur. By investigating the nature of the earliest cellular response in the lungs of vaccinated animals, we may be able to accelerate the memory response and improve vaccination protocols.
|
1 Cooper, A.M., et al. 1993. J. Exp. Med. 178:2243–2247.
REFERENCES
2 Cooper, A.M., et al. 1995. Immunology 84:423–432.[Medline]
3 Cooper, A.M., et al. 1997. J. Exp. Med. 186:39–46.
4 Cooper, A.M., et al. 2002. J. Immunol. 168:1322–1327.
5 Khader, S.A. et al. 2007. Nat. Immunol. 8:369–377.[CrossRef][Medline]![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|